Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Applied Nanoscience Announces International Patent Developments and Expansion of Intellectual Property Portfolio

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today announced that it has received formal notification for the issuance of a patent in Singapore for its core technology platform encompassing "Filtering Devices Incorporating Nanoparticles." The Company has already been issued this similarly broad patent in Taiwan. The patent covers three main ways of associating the nanoparticles with filter media: (1) having pellets of nanoparticles located adjacent to the filter media, (2) coating the filter media with a powder of nanoparticles, and (3) impregnating the nanoparticles into the filter media.

Applied Nanoscience Announces International Patent Developments and Expansion of Intellectual Property Portfolio

CARLSBAD, CA | Posted on May 14th, 2008

In addition, ANI has received formal communication that the issuance of this same patent is imminent in Russia along with written confirmation that the granting of a patent based upon a divisional application is expected soon in India.

"We are pleased with this recent trend of valuable developments tied to our global intellectual property efforts. We should be in a position in the very near future to disclose additional IP growth thanks to diligent efforts in over 50 countries," said Thomas K. Allen, President and CEO, ANI. "This protection, coupled with our proprietary silver NanoFense™ Technology, makes for attractive licensing opportunities within identified market segments."

The Company has received very positive notification relating to the patent application on their proprietary nanoparticle formulation from the USPTO.

####

About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.

For more information, please click here

Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464

Investor Relations

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Announcements

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project